Results 21 to 30 of about 31,242 (231)

What Is the Optimal Digoxin Level? Challenging Case of Fetal Atrial Flutter Treatment in a Monochorionic Diamniotic Twin

Medicina, 2023
Background: Atrial flutter is an infrequent yet potentially fatal arrhythmia. Digoxin is the preferred first-line treatment for fetal atrial flutter due to its efficacy and favorable safety profile.
Soo Jung Kim, Hee Do Jeon, So-Yeon Shim, Yi-Seul Kim, Mi-Hye Park, Kyung A. Lee   +5 more
doaj   +1 more source

Clinical Differences between Subtypes of Atrial Fibrillation and Flutter: Cross-Sectional Registry of 407 Patients

Arquivos Brasileiros de Cardiologia, 2015
Introduction: Atrial fibrillation and atrial flutter account for one third of hospitalizations due to arrhythmias, determining great social and economic impacts. In Brazil, data on hospital care of these patients is scarce.
Eduardo Dytz Almeida, Raphael Boesche Guimarães, Laura Siga Stephan, Alexandre Kreling Medeiros, Katia Foltz, Roberto Tofani Santanna, Leonardo Martins Pires, Marcelo Lapa Kruse, Gustavo Glotz de Lima, Tiago Luiz Luz Leiria   +9 more
doaj   +1 more source

Modes of Initiation of Two Types of Atrial Reentry in a Patient with Typical Atrial Flutter: Isthmus-dependent Micro-reentry versus Macro-reentry

Journal of Arrhythmia, 2005
We studied the modes of initiation of two types of atria] reentrant tachycardias (i.e., microreentry isthmus tachycardia and counterclockwise atrial flutter) in a 39-year-old male with typical atrial flutter.
Makoto Noda, MD, Fumio Suzuki, MD, Kazunori Sezaki, MD, Tetsuya Katsuno, MD, Michio Usui, MD, Mitsuaki Isobe, MD   +5 more
doaj   +1 more source

Cardiovascular Toxicity Associated With Bispecific Antibodies in Hematological Malignancies: A Comprehensive Pharmacovigilance Analysis

American Journal of Hematology, EarlyView.
ABSTRACT Cardiovascular adverse events (CVAEs) associated with bispecific T‐cell engaging antibodies (BsAbs) have not been systematically investigated across approved agents. In this disproportionality analysis of FAERS (December 2014–September 2025), reports listing BsAbs as the primary suspected drug (n = 7647) were compared with all other drugs in ...
Malak Munir, Ahmed Sayed, Dae Hyun Lee, Sanam Ghazi, Mustafa M. Houmsse, Saad Badat, Abdul Moeed, Avirup Guha, Daniel Addison, Narendranath Epperla   +9 more
wiley   +1 more source

Mobile health interventions to improve adherence to oral anticoagulant treatment: A systematic review and critical analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Non‐adherence to oral anticoagulants (OACs) is associated with significant morbidity and mortality. Mobile health (mHealth) interventions have been used to improve medication adherence across the three phases of initiation, implementation and persistence.
Non Davies, Elin Haf Davies, Dyfrig A. Hughes   +2 more
wiley   +1 more source

Trends in atrial flutter and atrial tachycardia research

Informatics in Medicine Unlocked, 2017
Background: Atrial flutter and atrial tachycardia are frequently observed arrhythmias that can be difficult to treat effectively with catheter ablation. It would be of interest to know the research directions for these arrhythmias in order to plan future
Edward J. Ciaccio, Angelo B. Biviano, Vivek Iyer, Hasan Garan   +3 more
doaj   +1 more source

Atrial fibrillation and atrial flutter in athletes [PDF]

British Journal of Sports Medicine, 2012
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice, with an estimated prevalence of 0.4% to 1% in the general population, increasing with age to 8% in those above 80 years. The recognised risk factors for developing AF include age, structural heart disease, hypertension, diabetes mellitus or hyperthyroidism.
Naiara, Calvo, Josep, Brugada, Marta, Sitges, Lluís, Mont   +3 more
openaire   +2 more sources

The Impact of a Visualized Steerable Sheath on Radiofrequency Catheter Ablation for First‐Time Atrial Fibrillation Ablation: A Prospective, Randomized, Single‐Blind Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background A 3D electroanatomical mapping (3D‐EAM) visualized steerable sheath was designed to improve catheter placement and reduce radiation exposure during ablation, an established treatment for atrial fibrillation (AF). However, prospective randomized data comparing the procedural and clinical outcomes of visualized and non‐visualized ...
Chun‐Kai Chen, Chih‐Chieh Yu, Min‐Tsun Liao, Hui‐Chun Huang, Yen‐Bin Liu   +4 more
wiley   +1 more source

Comparison of Immediate Versus Staged Complete Revascularization in Patients With Index PCI Coronary Complications: A Study on Clinical Outcomes and Predictors of Complications

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background In patients with acute coronary syndrome (ACS) and multivessel disease (MVD), complete revascularization (CR) improves clinical outcomes compared with culprit‐only percutaneous coronary intervention (PCI). However, the optimal timing of CR, immediate (ICR) versus staged (SCR), remains debated.
Alessandro Gabrielli, Jacob J. Elscot, William Camilleri, Hala Kakar, Eric Boersma, Nicolas M. Van Mieghem, Roberto Diletti, Wijnand K. Den Dekker   +7 more
wiley   +1 more source

Atrial flutter: from ECG to electroanatomical 3D mapping

Heart International, 2009
Atrial flutter is a common arrhythmia that may cause significant symptoms, including palpitations, dyspnea, chest pain and even syncope. Frequently it’s possible to diagnose atrial flutter with a 12-lead surface ECG, looking for distinctive waves in ...
Livio Dei Cas, Giuseppe Inama, Riccardo Raddino, Antonio Curnis, Giosuè Mascioli, Ornella Durin, Claudio Pedrinazzi   +6 more
doaj   +1 more source